Related Experiment Videos
Meningococcal infections. 5. Duration of polysaccharide-vaccine-induced antibody
Bulletin of the World Health Organization
|January 1, 1971
Abstract:
Serum antibodies induced in 12 volunteer subjects by injection of group A and group C meningococcal polysaccharide vaccines were found to persist for periods exceeding 14 months. Antibody response was measured by indirect haemagglutination and fluorescent antibody assays. Peak titres were reached in 2-8 weeks.
Insights
Serum antibodies from meningococcal polysaccharide vaccines (group A and C) persisted over 14 months in volunteers. Antibody levels peaked within 2-8 weeks, indicating a durable immune response to vaccination.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Neisseria meningitidis is a leading cause of bacterial meningitis.
- Meningococcal polysaccharide vaccines (MPVs) are crucial for preventing serogroup A and C infections.
- Understanding the duration of immune response to MPVs is vital for public health strategies.
Purpose of the Study:
- To evaluate the persistence of serum antibodies induced by group A and C meningococcal polysaccharide vaccines.
- To determine the timeframe for peak antibody titers following vaccination.
Main Methods:
- Indirect haemagglutination assay to quantify antibody levels.
- Fluorescent antibody assay for antibody detection.
- Longitudinal monitoring of antibody titers in 12 volunteer subjects.
Main Results:
- Serum antibodies persisted for over 14 months post-vaccination.
- Peak antibody titers were observed between 2 and 8 weeks after immunization.
- Consistent antibody response across subjects indicates vaccine efficacy.
Conclusions:
- Group A and C meningococcal polysaccharide vaccines induce long-lasting antibody protection.
- The observed antibody persistence supports the use of these vaccines in immunization programs.
- Further research may explore booster strategies based on antibody decay rates.